International Aerospace Enterprises, Inc.(fka IARO)

[linuspop]

CalbaTech's Subsidiary, LifeStem, Inc., Launches Major Effort for Collaborative Partner to Develop Stem Cell Delivery Device
PR Newswire - January 20, 2005 14:35

IRVINE, Calif., Jan 20, 2005 /PRNewswire-FirstCall via COMTEX/ -- CalbaTech, Inc. (OTC Bulletin Board: CLBE), an emerging life sciences company (http://www.CalbaTech.com) concentrating on providing products and platforms to the research market for biotech and pharmaceutical companies and to academic institutions, announced today that its wholly owned subsidiary, LifeStem, Inc., has launched a major project to develop its Stem Cell Delivery Device.

"Most stem cell research and development currently is concentrated on cellular therapeutics as opposed to the delivery of stem cells. Our subsidiary is confident that stem cell research, its applications, and specifically the necessary targeted delivery, will expand exponentially in the near future," said LifeStem President Dan Fulkerson, who pointed to the major efforts in California and elsewhere to research the role of stem cells in conquering some of mankind's most dreaded diseases.

"LifeStem is undertaking a major effort to find a collaborative partner in the prototype development of its stem cell delivery device and is discussing this possibility with several of the nation's leading medical device manufacturers," Mr. Fulkerson said.

"Our stem cell delivery device is a patent pending proprietary system for the regeneration of cardiac muscle post myocardial infarction. This device is designed for the targeted delivery of peripheral blood-derived autologous stem cells to diseased tissue for the purpose of regenerating healthy functional tissue," said Mr. Fulkerson. "The device is a disposable sheath placed over a rigid fiber optic endoscope, allowing diagnostic and delivery mechanisms. This provides the ability to detect dead and diseased cardiac tissue with the precision delivery of stem cells, thus promoting regeneration. Our system is compatible with endoscopes from the various manufacturers," said the President of LifeStem.

About CalbaTech

CalbaTech is focused on developing and providing products and platforms to the research market, both for biotech and pharmaceutical companies, as well as academic institutions. It is concentrating on acquiring, incubating and developing early stage life science based companies that are developing next generation products and technologies, both in the United States and in the United Kingdom. In addition to growth through acquisition, CalbaTech, comprised of three divisions, Molecular Applications, Research Reagents, and Cellular Therapeutics, is building an experienced and innovative scientific staff, including several notable members of its Scientific Advisory Board that intend to contribute breakthrough innovation in areas of biological discovery.

About LifeStem

LifeStem, a wholly owned subsidiary of CalbaTech, is positioning itself to become a leading supplier of "Cellular Logistics". The Company's focus is to provide services and technologies to facilitate the efficient acquisition and delivery of purified adult stem cells, development of stem cell delivery devices for clinical applications and clinical applications of specific stem cell based therapies. The Company has filed a patent application for an endoscopic stem cell delivery device that delivers stem cells into diseased or dead cardiac tissue.